Better mind the gap: addressing the shortage of HIV-positive women in clinical trials
Authors:
- Lorena GonzálezLGLorena González
- Annette HaberlAHAnnette Haberl
- Lorraine SherrLSLorraine Sherr
- Winnie Ssanyu-SserumaWSWinnie Ssanyu-Sseruma
- Sharon L WalmsleySWSharon L Walmsley
- 15 May 2010
- journal article
- opinion
- Published by Wolters Kluwer Health in AIDS
- Vol. 24 (8) , 1091-1094
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Gender differences in the treatment of HIV infectionPharmacological Research, 2008
- Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic reviewJournal of Antimicrobial Chemotherapy, 2007
- Antiretroviral pharmacokinetic profile: A review of sex differencesGender Medicine, 2007
- Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAARTAIDS, 2007
- Sex Differences in Antiretroviral Therapy-Associated Intolerance and Adverse EventsDrug Safety, 2005
- Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Hormone replacement therapy and heart disease: replacing dogma with data.Circulation, 2003
- Sex-Based Differences in the Effect of Digoxin for the Treatment of Heart FailureNew England Journal of Medicine, 2002
- Sex differences in HAART-associated dyslipidaemiaAIDS, 2001
- Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration PolicyNew England Journal of Medicine, 1993